COVID-19 research links

Victorian coronavirus data – Victorian Department of Health and Human Services
Coronavirus (COVID-19) vaccine data – Victorian Department of Health and Human Services
Wastewater testing – Victorian Department of Health and Human Services

Western Australia

Coronavirus COVID-19 in Western Australia – WA Health
COVID-19 vaccination program – WA Health

[Back to top]

First Nations COVID-19 resources and research

Resources

United Nations – Indigenous peoples and the COVID-19 pandemic: Considerations. Access here.
National Indigenous Australians Agency – Coronavirus (COVID-19). Links include government and territory resources. Access here.
Australian Government – Coronavirus (COVID-19) resources for Aboriginal and Torres Strait Islander people and remote communities. Access here.
Australian Government – Aboriginal and Torres Strait Islander COVID-19 Epidemiology Report 1: 28 February 2021. Access here.
Australian Government – COVID-19 Australia: Epidemiology Report 39 Reporting period ending 11 April 2021. Access here.
Australian Government – Information for Aboriginal and Torres Strait Islander peoples about COVID-19 vaccines. Access here.
Australian Government – Management Plan for Aboriginal and Torres Strait Islander Populations. Access here.
NACCHO and NCIRS – Information about COVID-19 vaccines for Aboriginal and Torres Strait Islander People. Access here.
NACCHO – Coronavirus (COVID-19) Updates and Information. Access here.

Research papers, tools and comment

Kennedy et al, “You can’t replace that feeling of connection to culture and country”: Aboriginal and Torres Strait Islander Parents’ experiences of the COVID-19 pandemic, International Journal of Environmental Research and Public Health, 2022, 19(24), 16724. Access here.
Heris et al, Key features of a trauma-informed public health emergency approach: A rapid review, Frontiers in Public Health, published 28 November 2020. Access here.
Graham et al, A culturally responsive trauma-informed public health emergency framework for Aboriginal and Torres Strait Islander Communities in Australia, developed during COVID-19, International Journal of Environmental Research and Public Health, published online 24 November 2022. Access here.
Crooks et al, Engage, understand, listen and act: evaluation of Community Panels to privilege First Nations voices in pandemic planning and response in Australia, BMJ Global Health, 2022;7:e009114. Access here.
Graham et al, Aboriginal peoples’ perspectives about COVID-19 vaccines and motivations to seek vaccination: a qualitative study, BMJ Global Health, published online 20 July 2022. Access here.
Fredericks et al, The Burden of the Beast. Countering conspiracies and misinformation within Indigenous communities in Australia, M/C Journal, published online 16 March 2022. Access here.
Fredericks et al, Using systems thinking to better understand risks and protective factors for urban Indigenous peoples during COVID-19, published December 2021. Access here.
Gall et al, Self-reported wellbeing and health-related quality of life of Aboriginal and Torres Strait Islander people pre and post the first wave of the COVID-19 2020 pandemic, Australian and New Zealand Journal of Public Health, published online 21 December 2021. Access here.
Komesaroff et al, COVID-19 restrictions should only be lifted when it is safe to do so for Aboriginal communities, Internal Medicine Journal, published online 12 October 2021. Access here.
Naren et al, Role of Aboriginal Health Practitioners in administering and increasing COVID-19 vaccination rates in a Victorian Aboriginal Community Controlled Health Organisation, Rural and Remote Health, published online 8 October 2021. Access here.
Stanley et al, Australian First Nations response to the pandemic: A dramatic reversal of the ‘gap’, Journal of Paediatrics and Child Health, published online 30 September 2021. Access here.
Usher et al, Influence of COVID-19 on the preventive health behaviours of Indigenous Peoples of Australia residing in New South Wales: a mixed-method study protocol, BMJ Open, published online 22 September 2021. Access here.
Dudgeon et al, Mental health and well-being of Aboriginal and Torres Strait Islander peoples in Australia during COVID-19, Australian Journal of Social Issues, published online 20 September 2021. Access here.
Hui et al, Modelling testing and response strategies for COVID-19 outbreaks in remote Australian Aboriginal communities, BMC Infectious Diseases, 21, Article number: 929 (2021). Access here.
McCalman et al, Leading with local solutions to keep Yarrabah safe: a grounded theory study of an Aboriginal community-controlled health organisation’s response to COVID-19, BMC Health Services Research, published online 23 July 2021. Access here.
Wilson-Matenga et al, Partnership, trust and respect: NSW’s response to COVID-19 among Aboriginal people, Australian and New Zealand Journal of Public Health, published online 28 June 2021. Access here.
Reid, Opinion: Why Australia’s real covid-19 success belongs to the First Nations, Washington Post, published online 23 March 2021. Access here.
Carroll et al, Indigenous Peoples’ data during COVID-19: From external to internal, Frontiers in Sociology, published online 29 March 2021. Access here.
Tsosie et al, Genomics data: the broken promise is to Indigenous people, Nature, published online 19 March 2021. Access here.
Follent et al, The indirect impacts of COVID-19 on Aboriginal communities across New South Wales, Medical Journal of Australia, published online 28 February 2021. Access here.
Walker et al, Connection to… Addressing digital inequities in supporting the well-being of young Indigenous Australians in the wake of COVID-19, International Journal of Environmental Research and Public Health, published online 22 February 2021. Access here.
Arrazola et al, COVID-19 mortality among American Indian and Alaska Native persons — 14 States, January–June 2020, CDC Morbidity and Mortality Weekly Report, December 11, 2020, Vol. 69, No. 49, pages 1853–1856. Access here.
Chisholm et al, A model of population dynamics with complex household structure and mobility: implications for transmission and control of communicable diseases, PeerJ, 8:e10203, published online 3 November 2020. Access here.
Campbell et al, Health services in northern Australia depend on student placements post COVID-19, Australian and New Zealand Journal of Public Health, published online 26 October 2020. Access here.
Campbell et al, Allied health service–learning student placements in remote northern Australia during COVID-19, The Australian Journal of Rural Health, published online 27 September 2020. Access here.
Moodie et al, Roadmap to recovery: Reporting on a research taskforce supporting Indigenous responses to COVID-19 in Australia, Australian Journal of Social Issues, published online 22 September 2020. Access here.
Bond et al, “Now we say Black Lives Matter but … the fact of the matter is, we just Black matter to them”, Medical Journal Australia, published online 17 August 2020. Access here.
Thresia et al, The health of Indigenous populations in South Asia: A critical review in a critical time, International Journal of Health Services, published online 12 August 2020. Access here.
Cupertino et al, COVID-19 and Brazilian Indigenous Populations, The American Society of Tropical Medicine and Hygiene, published online 2 August 2020. Access here.
Yashadhana et al, Indigenous Australians at increased risk of COVID-19 due to existing health and socioeconomic inequities, Lancet Regional Health – Western Pacific, published online 27 July 2020. Access here.
Usher et al, COVID-19 and social restrictions: the potential mental health impact of social distancing and isolation for young Indigenous Australians, Australasian Psychiatry, published online 26 July 2020. Access here.
Eades et al, Australia’s First Nations’ response to the COVID-19 pandemic, Lancet, published online 25 July 2020. Access here.
Close et al, Contact Tracing for Native Americans in Rural Arizona, NEJM, published online 16 July 2020. Access here.
McLeod et al, COVID-19: we must not forget about Indigenous health and equity, Aust N Z J Public Health, published online 6 July 2020. Access here.
Finlay and Wenitong, Aboriginal Community Controlled Health Organisations are taking a leading role in COVID-19 health communication, Australian and New Zealand Journal of Public Health, published online 24 June 2020. Access here.
Power et al, COVID-19 and Indigenous Peoples: An imperative for action, Journal of Clinical Nursing, published online 29 May 2020. Access here.
Júnior et al, The mental health of those whose rights have been taken away: An essay on the mental health of indigenous peoples in the face of the 2019 Coronavirus (2019-nCoV) outbreak, Psychiatry Research, published online 13 May 2020. Access here.
León-Martínez et al, Critical review of social, environmental and health risk factors in the Mexican indigenous population and their capacity to respond to the COVID-19, Science of the Total Environment, published online 12 May 2020. Access here.
Meneses-Navarro et al, The challenges facing indigenous communities in Latin America as they confront the COVID-19 pandemic, International Journal for Equity in Health, published online 7 May 2020. Access here.
Crooks et al, First Nations people leading the way in COVID-19 pandemic planning, response and management, Medical Journal of Australia, published online 29 April 2020. Access here.
Kidell-Monroe et al, Inuit communities can beat COVID-19 and tuberculosis, Lancet Public Health, published online 24 April 2020. Access here.
Dreise and Ali, COVID -19: A practical tool for preparedness and planning in an Indigenous primary care setting in Canada, Canadian Family Physician, published online 15 April 2020. Access here.
Soto and Hakim, Medical basis for increased susceptibility of COVID-19 among the Navajo and other Indigenous Tribes, Preprints, published online 14 April 2020. Access here.
Markham et al, Indigenous Australians and the COVID-19 crisis: perspectives on public policy, Topical Issue no. 1/2020, Centre for Aboriginal Economic Policy Research, Australian National University, Canberra. Access here.
Bond and Singh, More than a refresh required for closing the gap of Indigenous health inequality, Medical Journal of Australia, published online 16 March 2020. Access here.

[Back to top]

COVID-19 planning and technical guidance

A living WHO guideline on drugs to prevent covid-19, online platform to access latest version. Access here.
World Health Organization, WHO COVID-19 Preparedness and Response Progress Report – 1 February to 30 June 2020. Access here.
World Health Organization, A global framework to ensure equitable and fair distribution of COVID-19 products, Final working version 9 September 2020. Access here.
World Health Organization, 2019 Novel Coronavirus (2019‑nCoV): Strategic preparedness and response plan, draft as of 3 February 2020. Access here.
World Health Organization, A guide to WHO’s guidance on COVID-19. Access here.
World Health Organization, Country & Technical Guidance – Coronavirus disease (COVID-19), online. Access here
World Health Organization, Origins of the SARS-CoV-2 virus, online 26 March 2021. Access here.

[Back to top]

Protocols

World Health Organization, Country & Technical Guidance – Coronavirus disease (COVID-19). Access here.
World Health Organization, Household transmission investigation protocol for 2019-novel coronavirus (2019-nCoV) infection, Version: 1.1, 25 January 2020. Access here.
World Health Organization, Protocol for assessment of potential risk factors for 2019-novel coronavirus (2019-nCoV) infection among health care workers in a health care setting, version 1.2, 3 February 2020. Access here.
World Health Organization, The First Few X (FFX) Cases and contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection, version 2, 10 February 2020. Access here.

[Back to top]

Evidence reviews

Australian Academy of Science, Rapid research information forum. Access here.
Cochrane, Coronavirus (COVID-19) – Cochrane resources and news. Access here.
Hunter New England Population Health Strategic COVID-19 Research Group, Saliva-based collection as an alternative to nasopharyngeal swab for SARS-CoV-2 testing: Preliminary analysis. Access here.
Hunter New England Population Health Strategic COVID-19 Research Group, The potential benefit of testing saliva versus nasopharyngeal swabs (NPS) for COVID-19. Access here.

[Back to top]

Editorials and comment

McVernon and Liberman, WHO keeps covid-19 a public health emergency of international concern, BMJ, published online 6 Match 2023. Access here.
Gilbert, Aged care residents — and everybody else — would benefit from better control of COVID-19 transmission, Medical Journal of Australia, published online 4 February 2023. Access here.
Katz, Challenges of tracking funding for pandemic preparedness and response, Lancet Global Health, published online 24 January 2023. Access here.
Marks et al, Urgent need for next-generation COVID-19 vaccines, JAMA Network, published online 9 December 2022. Access here.
Moore et al, A research and development (R&D) roadmap for broadly protective coronavirus vaccines: Setting a path to address coronavirus threats, Vaccine, published online 6 October 2022. Access here.
Sridhar et al, The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022, Nature Communications, published online 2 October 2022. Access here.
Bollyky et al, Trust made the difference for democracies in COVID-19, Lancet, published online 27 August 2022. Access here.
Antonelli et al, Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2, Lancet, published online 18 June 2022. Access here.
Editorial, Does the world still need new Covid-19 vaccines? NEJM, published online 2 June 2022. Access here.
Editorial, COVID-19 pandemic: what’s next for public health?, Lancet Public Health, published 1 May 2022. Access here.
Swets et al, SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses, Lancet, published online 25 March 2022. Access here.
Transmission of SARS-CoV-2 from mother to baby is rare, BMJ, published online 16 March 2022. Access here.
EU-Response investigators group et al, Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group, Clinical Microbiology and Infectious Diseases, published online 7 November 2021. Access here.
Webb et al, Glucocorticoid dose in COVID-19: Lessons for clinical trials during a pandemic, JAMA, published online 21 October 2021. Access here.
ISARIC Clinical Characterisation Group, The value of open-source clinical science in pandemic response: lessons from ISARIC, Lancet Infectious Diseases, published online 4 October 2021. Access here.
Normark et al, Heterologous ChAdOx1 nCoV-19 and mRNA-1273 vaccination, NEJM, published online 9 September 2021. Access here.
Telford et al, Chronicles of a pandemic: How France coordinated the scientific research response to COVID-19, Infectious Diseases Now, published online 28 August 2021. Access here.
Harris et al, Effect of vaccination on household transmission of SARS-CoV-2 in England, NEJM, published online 19 August 2021. Access here.
Munblit et al, Setting priorities to address research gaps in long-term COVID-19 outcomes in children, JAMA Pediatrics, published online 2 August 2021. Access here.
Dut, The experience of South Sudanese migrant families during the COVID-19 pandemic in Melbourne, Australian and New Zealand Journal of Public Health, published online 26 July 2021. Access here.
Chu et al, Household transmission of SARS-CoV-2 from children and adolescents, NEJM, published online 21 July 2021. Access here.
Bowen et al, Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID‐19, Medical Journal of Australia, published online 19 July 2021. Access here.
Seidler et al, The landscape of COVID-19 trials in Australia, Medical Journal of Australia, published online 18 July 2021. Access here.
Scales et al, The Covid-19 infodemic — Applying the epidemiologic model to counter misinformation, NEJM, published online 12 May 2021. Access here.
Shaw et al, Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data, Lancet, published online 12 May 2021. Access here.
Editorial, 2021: the beginning of a new era of immunisations? Lancet, published online 24 April 2021. Access here.
Greenhalgh et al, Ten scientific reasons in support of airborne transmission of SARS-CoV-2, Lancet, published online 15 April 2021. Access here.
Editorial, Covid-19 has redefined airborne transmission, BMJ, published online 14 April 2021. Access here.
Cooper, The coronavirus variants don’t seem to be highly variable so far, Scientific American, published online 24 March 2021. Access here.
Keehner et al, SARS-CoV-2 infection after vaccination in health care workers in California, NEJM, published online 23 March 2021. Access here.
Carvalho et al, The first 12 months of COVID-19: a timeline of immunological insights, Nature Reviews Immunology, published online 15 March 2021. Access here.
Skegg et al, Future scenarios for the COVID-19 pandemic, Lancet, published online 15 February 2021. Access here.
Editorial, Genomic sequencing in pandemics, Lancet, published online 5 February 2021. Access here.
Cevik et al, Support for self-isolation is critical in covid-19 response, BMJ, published online 27 January 2021. Access here.
Gorna et al, Long COVID guidelines need to reflect lived experience, Lancet, published online 21 December 2020. Access here.
Burgess et al, The COVID-19 vaccines rush: participatory community engagement matters more than ever, Lancet, published online 10 December 2020. Access here.
Soto-Perez-de-Celis, Social media, ageism, and older adults during the COVID-19 pandemic, EClinicalMedicine, published online 20 November 2020. Access here.
Karlsson et al, The known unknowns of T cell immunity to COVID-19, Science Immunology, published online 18 November 2020. Access here.
Buising et al, A hospital‐wide response to multiple outbreaks of COVID‐19 in health care workers: lessons learned from the field, Medical Journal of Australia, published online 15 November 2020. Access here.
Richter et al, How to establish an academic SARS-CoV-2 testing laboratory, Nature Microbiology, published online 2 November 2020. Access here.
Editorial, COVID-19 transmission—up in the air, Lancet Respiratory Medicine, published online 29 October 2020. Access here.
The COVID-19 Research GloPID-R Synergies Meeting Working Group & Meeting Co-chairs, Ending COVID-19: progress and gaps in research—highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings, BMC Medicine, published online 29 October 2020. Access here.
Prather et al, Airborne transmission of SARS-CoV-2, Science, published online 16 October 2020. Access here.
Shaman and Galanti, Will SARS-CoV-2 become endemic? Science, published online 14 October 2020. Access here.
Gilbert, COVID‐19 in a Sydney nursing home: a case study and lessons learnt, Medical Journal of Australia, published online 17 October 2020. Access here.
Nature editorial, Long COVID: let patients help define long-lasting COVID symptoms, Nature, published online 7 October 2020. Access here.
del Rio et al, Long-term health consequences of COVID-19, JAMA, published online 5 October 2020. Access here.
McMahon et al, Leveraging the advances in HIV for COVID-19, Lancet, published online 3 October 2020. Access here.
Perego et al, Why we need to keep using the patient made term “Long Covid”, BMJ, published online 1 October 2020. Access here.
Britton et al, COVID-19 public health measures and respiratory syncytial virus, Lancet Child and Adolescent Health, published online 18 September 2020. Access here.
Fontanet and Cauchemez, COVID-19 herd immunity: where are we?, Nature Reviews Immunology, published online 9 September 2020. Access here.
Millar et al, Apples and oranges: international comparisons of COVID-19 observational studies in ICUs, Lancet Respiratory Medicine, published online 21 August. Access here.
Park et al, Clinical trials of disease stages in COVID 19: complicated and often misinterpreted, Lancet Global Health, published online 20 August 2020. Access here.
Norton et al, Strengthening the global effort on COVID-19 research, Lancet, published online 16 July 2020. Access here.
Sette and Crotty, Pre-existing immunity to SARS-CoV-2: the knowns and unknowns, Nature Reviews Immunology, published online 7 July 2020. Access here.
Halpern et al, Cognitive bias and public health policy during the COVID-19 pandemic, JAMA, published online 29 June 2020. Access here.
Taylor et al, Solidarity in the wake of COVID-19: reimagining the International Health Regulations, The Lancet, published online 19 June 2020. Access here.
Okell et al, Have deaths from COVID-19 in Europe plateaued due to herd immunity?, The Lancet, published online 11 June 2020. Access here.
Mullard, COVID-19 vaccine development pipeline gears up, Lancet, published online 6 June 2020. Access here.
Smith, The challenges of establishing adequate capacity for SARS‐CoV‐2 testing, Medical Journal Australia, published online 1 June 2020. Access here.
Carsetti et al, The immune system of children: the key to understanding SARS-CoV-2 susceptibility?, The Lancet Child & Adolescent Health, published online 1 June 2020. Access here.
Editorial, Sustained suppression, Nature Biomedical Engineering, published online 13 May 2020. Access here.
Subbarao, SARS-CoV-2: A New Song Recalls an Old Melody, Cell Host & Microbe, published online 13 May 2020. Access here.
Gilbert, SARS, MERS and COVID-19—new threats; old lessons, International Journal of Epidemiology, posted online 3 May 2020. Access here.
Lipsitch et al, Antibody testing will enhance the power and accuracy of COVID-19-prevention trials, Nature Medicine, published online 27 April 2020. Access here.
Muhi et al, COVID-19 in Australian healthcare workers: Early experience of the Royal Melbourne Hospital emphasises the importance of community acquisition, Medical Journal Australia, published online 23 April 2020. Access here.
Plotkin and Caplan, Extraordinary diseases require extraordinary solutions, Vaccine, published online 20 April 2020. Access here.
Day, Covid-19: four fifths of cases are asymptomatic, China figures indicate, BMJ, published online 20 April 2020. Access here.
Editorial, Humanity tested, Nature Biomedical Engineering, published online 8 April 2020. Access here.
COVID-19 Clinical Research Coalition, Global coalition to accelerate COVID-19 clinical research in resource-limited settings, Lancet, published online 2 April 2020. Access here.
Peeples, News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine, PNAS, published online 30 March 2020. Access here.
Lurie et al, Developing Covid-19 vaccines at pandemic speed, NEJM, published online 30 March 2020. Access here.
Usher, WHO launches crowdfund for COVID-19 response, Lancet, published online 28 March 2020. Access here.
Cluver et al, Parenting in a time of COVID-19, Lancet, published online 25 March 2020. Access here.
Ritchie and Singanayagam, Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? Lancet, published online 24 March 2020. Access here.
Meyer and Martin, How to reduce COVID-19 spread in long-term care facilities: Challenges and recommendations, Clinicians’ Biosecurity News, published online 23 March 2020. Access here.
Kinner et al, Prisons and custodial settings are part of a comprehensive response to COVID-19, Lancet Public Health, published online 17 March 2020. Access here.
Chen et al, Detection of Covid-19 in children in early January 2020 in Wuhan, China, NEJM, published online 12 March 2020. Access here.
Sharfstein et al, Diagnostic testing for the novel coronavirus, JAMA, published online 9 March 2020. Access here.
Fauci et al, Covid-19 — Navigating the uncharted, NEJM, published online 28 February 2020. Access here.
Bill Gates, Responding to Covid-19 — A once-in-a-century pandemic? NEJM, published online 28 February 2020. Access here.
The novel coronavirus outbreak: What we know and what we don’t, Cell, published online 19 February 2020. Access here.
Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China, NEJM, published online 18 February 2020. Access here.
Li and de Clercq, Therapeutic options for the 2019 novel coronavirus (2019-nCoV), Nature Reviews Drug Discovery, published online 10 February 2020. Access here.
Calling all coronavirus researchers: keep sharing, stay open, Nature, published online 4 Feb 2020. Access here.
Phelan et al, The Novel Coronavirus Originating in Wuhan, China – Challenges for Global Health Governance, JAMA, published online Jan 30, 2020. Access here.
Emerging understandings of 2019-nCoV, Lancet, published online Jan 24, 2020. Access here.
Wang et al, A novel coronavirus outbreak of global health concern, Lancet, published online Jan 24, 2020. Access here.
Heymann, Data sharing and outbreaks: best practice exemplified, Lancet, published online Jan 24, 2020. Access here.
Munster et al, A novel coronavirus emerging in China – Key questions for impact assessment, NEJM, published online Jan 24, 2020. Access here.

[Back to top]

Research papers (most recent first)

Basic epidemiological and clinical characterisation

Xu et al, Long-term gastrointestinal outcomes of COVID-19, Nature Communications, published 7 March 2023. Access here.
Stein et al, SARS-CoV-2 infection and persistence in the human body and brain at autopsy, Nature, published online 14 December 2022. Access here.
McQuilten et al, Anticoagulation strategies in non–critically ill patients with Covid-19, NEJM Evidence, published online 10 December 2022. Access here.
Hessami et al, COVID-19 pandemic and infant neurodevelopmental impairment. A systematic review and meta-analysis, JAMA Network Open, published online 28 November 2022. Access here.
Gonçalves et al, An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients, Elife, published online 5 October 2022. Access here.
Daitch et al, Characteristics of long COVID among older adults: a cross-sectional study, International Journal of Infectious Diseases, published online 30 September 2022. Access here.
Xu et al, Long-term neurologic outcomes of COVID-19, Nature Medicine, published online 22 September 2022. Access here.
Martínez-Colón et al, SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages, Science Translational Medicine, published online 22 September 2022. Access here.
Reyes et al, Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study, Critical Care, published online 13 September 2022. Access here.
Puntmann et al, Long-term cardiac pathology in individuals with mild initial COVID-19 illness, Nature Medicine, published online 5 September 2022. Access here.
Hernández-Mitre et al, Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: A structured, narrative review, Clinical Pharmacokinetics, published online 30 August 2022. Access here.
Ezzatva et al, Physical activity and risk of infection, severity and mortality of COVID-19: a systematic review and non-linear dose–response meta-analysis of data from 1 853 610 adults, British Journal of Sports Medicine, published online 22 August 2022. Access here.
Ballering et al, Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study, Lancet, published online 6 August 2022. Access here.
ISARIC Clinical Characterization Group, ISARIC-COVID-19 dataset: A prospective, standardized, global dataset of patients hospitalized with COVID-19, Scientific Data, published online 22 July 2022. Access here.
Pekar et al, The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2, Science, published online 26 July 2022. Access here.
Thoma et al, All-cause maternal mortality in the US before vs during the COVID-19 pandemic, JAMA Network Open, published online 28 June 2022. Access here.
Liu et al, Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection [preprint], Preprint with Lancet, published online 21 June 2022. Access here.
Lewis et al, Transmission of SARS-CoV-2 in standardised first few X cases and household transmission investigations: A systematic review and meta-analysis, Influenza and Other Respiratory Viruses, published online 16 June 2022. Access here.
Begum et al, People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia, Medical Journal of Australia, published online 9 June 2022. Access here.
Coburn et al, Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the United States, JAMA Network Open, published online 7 June 2022. Access here.
Quandt et al, Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes, Science Immunology, Published 2 June 2022. Access here.
Al-Aly et al, Long COVID after breakthrough SARS-CoV-2 infection, Nature Medicine, published online 25 May 2022. Access here.
Eden et al, Off-season RSV epidemics in Australia after easing of COVID-19 restrictions, Nature Communications, published online 24 May 2022. Access here.
Huang et al, Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study, Lancet Respiratory Medicine, published online 11 May 2022. Access here.
McCafferty et al, Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C, Nature Communications, published online 2 May 2022. Access here.
Wainstein et al including ISARIC Clinical Characterisation Group, Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol, PLoS Medicine, published online 20 April 2022. Access here.
Ammirati et al, Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis, Circulation, published online 11 April 2022. Access here.
REMAP-CAP Writing Committee et al, Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: A randomized clinical trial, JAMA, published online 22 March 2022. Access here.
Vette et al, Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-specific antibodies in Australia after the first epidemic wave in 2020: A national survey, Open Forum Infectious Diseases, Volume 9, Issue 3, March 2022, ofac002. Access here.
Hernandez-Romieu et al, Prevalence of select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-CoV-2, JAMA Network Open, published online 4 February 2022. Access here.
Rowe et al, Complications following SARS-CoV-2 infection in Victoria, Australia: A record linkage study, [preprint] Lancet, published online 3 February 2022. Access here.
COVID-19 National Preparedness Collaborators, Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021, Lancet, published online 1 February 2022. Access here.
Su et al, Multiple early factors anticipate post-acute COVID-19 sequelae, Cell, published online 24 January 2022. Access here.
Axfors et al, Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials, BMC Infectious Diseases, 2021 November 20:1170. Access here.
Wurzel et al, Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study, BMJ Open, 2021 Nov 8;11(11):e054510. Access here.
Writing Committee for the REMAP-CAP Investigators, Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19. A randomized clinical trial, JAMA, 2021 Nov 2;326(17):1690-1702. Access here.
El-Heneidy et al, Respiratory virus detection during the COVID-19 pandemic in Queensland, Australia, Australian and New Zealand Journal of Public Health, published online 14 October 2021. Access here.
REMAP-CAP, ACTIV-4a, and ATTACC Investigators, Therapeutic anticoagulation with heparin in critically ill patients with Covid-19, NEJM, published online 26 August 2021. Access here.
ATTACC, ACTIV-4a, and REMAP-CAP Investigators, Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19, NEJM, published online 26 August 2021. Access here.
Sah et al, Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis, PNAS, August 24, 2021 118 (34) e2109229118. Access here.
Schell et al, Essential Emergency and Critical Care: a consensus among global clinical experts, BMJ Global Health, 2021;6:e006585. Access here.
Read et al, Hospital-acquired SARS-CoV-2 infection in the UK’s first COVID-19 pandemic wave, Lancet, published online 12 August 2021. Access here.
Daniels et al, Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, PLOS ONE, published online 15 July 2021. Access here.
Davis et al, Characterizing long COVID in an international cohort: 7 months of symptoms and their impact, EClinical Medicine, published online 15 July 2021. Access here.
Liu et al, Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia, Lancet Regional Health, published online 24 June 2021. Access here.
Nasserie et al, Assessment of the frequency and variety of persistent symptoms among patients with COVID-19.
A Systematic Review, JAMA Network Open, published online 26 May 2021. Access here.
Manoharan et al, Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review, PLOS One, published online 18 May 2021. Access here.
Drake et al, Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study, Lancet Rheumatology, published online 7 May 2021. Access here.
Wu et al, 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study, Lancet Respiratory Medicine, published online 5 May 2021. Access here.
Gao et al, Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study, Lancet Diabetes and Endocrinology, published online 28 April 2021. Access here.
Villar et al, Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 wnfection. The INTERCOVID multinational cohort study, JAMA Pediatrics, published online 22 April 2021. Access here.
Say et al, Post-acute COVID-19 outcomes in children with mild and asymptomatic disease, Lancet Child and Adolescent Health, published online 20 April 2021. Access here.
Perl et al, SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women, JAMA, published online 12 April 2021. Access here.
Shlomai et al, Neonatal SARS-CoV-2 infections in breastfeeding mothers, Pediatrics, April 2021, e2020010918. Access here.
Hall et al, SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN), Lancet, published online 9 April 2021. Access here.
Nalbandian et al, Post-acute COVID-19 syndrome, Nature Medicine, published 22 March 2021. Access here.
Hansen et al, Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study, Lancet, published online 17 March 2021. Access here.
Bearse et al, Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19, Modern Pathology, published online 17 March 2021. Access here.
Chen et al, Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis, Lancet Global Health, published online 8 March 2021. Access here.
Edwards et al, Exhaled aerosol increases with COVID-19 infection, age, and obesity, PNAS, published online 23 February 2021. Access here.
Oran and Topol, The proportion of SARS-CoV-2 infections that are asymptomatic. A Systematic Review, Annals of Internal Medicine, published online 22 January 2021. Access here.
Huang et al, 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study, Lancet, published online 8 January 2021. Access here.
Pullano et al, Underdetection of COVID-19 cases in France threatens epidemic control, Nature, published online 21 December 2020. Access here.
Peckham et al, Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission, Nature Communications, published online 9 December 2020. Access here.
Buss et al, Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic, Science, published online 8 December 2020. Access here.
Trenholme et al, COVID-19 and infant hospitalizations for seasonal respiratory virus infections, New Zealand, 2020, Emerging Infectious Diseases, published online 2 December 2020. Access here.
WHO Solidarity Trial Consortium, Repurposed antiviral drugs for Covid-19 — Interim WHO Solidarity Trial results, NEJM, published online 2 December 2020. Access here.
King et al Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure, PLoS ONE, published online 23 November 2020. Access here.
Mudd et al, Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm, Science, published online 13 November 2020. Access here.
Zietz et al, Associations between blood type and COVID-19 infection, intubation, and death, Nature Communications, published online 13 November 2020. Access here.
Gidding et al, Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020, Medical Journal of Australia, published online 11 November 2020. Access here.
Bussani et al, Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology, EBioMedicine, published online 3 November 2020. Access here.
Botta et al, Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study, Lancet Respiratory Medicine, published online 23 October 2020. Access here.
Figueiredo‐Campos et al, Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset, European Journal of Immunology, published online 22 October. Access here.
Clift et al, COVID-19 mortality risk in Down syndrome: Results from a cohort study of 8 million adults, Annals of Internal Medicine, published online 21 October 2020. Access here.
Leisman et al, Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes, Lancet Respiratory Medicine, published online 16 October 2020. Access here.
Jefferies et al, COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study, Lancet Public Health, published online 13 October 2020. Access here.
Makaronidis et al, Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study, PLoS Medicine, published online 1 October 2020. Access here.
Hallal et al, SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys, Lancet Global Health, published online 23 September 2020. Access here.
The Writing Committee for the REMAP-CAP Investigators, Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19. The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial, JAMA, published online 2 September 2020. Access here.
Grasselli et al, Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study, Lancet Respiratory Medicine, published online 27 August 2020. Access here.
Spinner et al, Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19. A randomized clinical trial, JAMA Network Open, published online 21 August 2020. Access here.
Yonker et al, Pediatric SARS-CoV-2: Clinical presentation, infectivity, and immune responses, Journal of Pediatrics, published online 19 August 2020. Access here.
Lee et al, Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea, JAMA Internal Medicine, published online 6 August 2020. Access here.
Gupta et al, Factors associated wth death in critically ill patients with coronavirus disease 2019 in the US, JAMA Internal Medicine, published online 15 July 2020. Access here.
Pollán et al, Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study, The Lancet, published online 6 July 2020. Access here.
Feldstein et al, Multisystem inflammatory syndrome in U.S. children and adolescents, NEJM, published online 29 June 2020. Access here.
Dufort et al, Multisystem inflammatory syndrome in children in New York State, NEJM, published online 29 June 2020. Access here.
Vizcarra et al, Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort, Lancet HIV, published online 28 May 2020. Access here.
Cummings et al, Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study, Lancet, published online 19 May 2020. Access here.
Verdoni et al, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, published online 13 May 2020. Access here.
Salje et al, Estimating the burden of SARS-CoV-2 in France, Science, published online 13 May 2020. Access here.
Hooker et al, Trajectories of hospital infection control: Using non-representational theory to understand and improve infection prevention and control, Social Science & Medicine, published online 5 May 2020. Access here.
Bi et al, Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study, Lancet Infectious Diseases, published online 27 April 2020. Access here.
Davis et al, Clinical trials for the prevention and treatment of coronavirus disease 2019 (COVID-19): The current state of play, Medical Journal of Australia [preprint version], pre-print published online 27 April 2020. Access here.
Arons et al, Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility, NEJM, published online 24 April 2020. Access here.
Yong et al, Connecting clusters of COVID-19: an epidemiological and serological investigation, Lancet Infectious Diseases, published online 21 April 2020. Access here.
Dondorp et al, Respiratory support in novel coronavirus disease (COVID-19) patients, with a focus on resource-limited settings, The American Journal of Tropical Medicine and Hygiene, published online 21 April 2020. Access here.
Grasselli et al, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy, JAMA, published online 6 April 2020. Access here.
ISARIC – International Severe Acute Respiratory and Emerging Infections Consortium, Clinical data report, published online 2 April 2020. Access here.
Ferretti et al, Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing, Science, published online 31 March 2020. Access here.
Zeng et al, Neonatal early-onset Infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China, JAMA Pediatrics, published online 26 March 2020. Access here.
Thevarajan et al, Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19, Nature Medicine, published on 16 March 2020. Access here.
Li et al, Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2), Science, published on 16 March 2020. Access here.
Tang et al, Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China, Emerging Infectious Diseases, published online 9 March 2020. Access here.
Zheng et al, COVID-19 and the cardiovascular system, Nature Reviews Cardiology, published online 5 March 2020. Access here.
Guan et al, Clinical characteristics of coronavirus disease 2019 in China, NEJM, published online 28 February 2020. Access here.
Lee et al, COVID-19 pneumonia: what has CT taught us?, Lancet Infectious Diseases, published online 24 February 2020. Access here.
Yang et al, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respiratory Medicine, published online 24 February 2020. Access here.
Wu and McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China – Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, published online 24 February 2020. Access here.
China CDC, Vital surveillances: The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020, China CDC Weekly, published online February 17 2020. Access here.
Wang et al, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China, JAMA, published online February 7, 2020. Access here.
Chen et al, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, published online Jan 29 2020. Access here.
Backer et al, The incubation period of 2019-nCoV infections among travellers from Wuhan, China, medRxiv, posted Jan 28 2020. Access here.
Huang et al, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, published online Jan 24, 2020. Access here.
Zhu et al, A novel coronavirus from patients with pneumonia in China, 2019, NEJM, published online Jan 24 2020. Access here.
Wu et al, Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020, Eurosurveillance, published online Jan 23 2020. Access here.

[Back to top]

Transmission

Marcato et al, Evaluation of the Australian first few X household transmission project for COVID-19, BMC Public Health, published 6 January 2023. Access here.
Hakki et al, Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study, Lancet Respiratory Medicine, published online 18 August 2022. Access here.
Tosif et al, Virology and immune dynamics reveal high household transmission of ancestral SARS-CoV-2 strain, Pediatric Allergy and Immunology, published online 11 July 2022. Access here.
Meredith et al, Routine surveillance and vaccination on a university campus during the spread of the SARS-CoV-2 Omicron variant, JAMA Network Open, published online 18 May 2022. Access here.
Trauer et al, Understanding how Victoria, Australia gained control of its second COVID-19 wave, Nature Communications, 12, Article number: 6266 (2021). Access here.
Sera et al, A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries, Nature Communications, published online 13 October 2021. Access here.
Paul et al, Association of age and pediatric household transmission of SARS-CoV-2 infection, JAMA Pediatrics, published online 16 August. Access here.
Whaley et al, Assessing the association between social gatherings and COVID-19 risk using birthdays, JAMA Internal Medicine, published online 21 June 2021. Access here.
Katelaris et al, Epidemiologic Evidence for airborne transmission of SARS-CoV-2 during church singing, Australia, 2020, Emerging Infectious Diseases, 2021;27(6):1677-1680. Access here.
Audsley et al, Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19), Infection Control and Hospital Epidemiology, published online 10 May 2021. Access here.
Metlay et al, Household transmission of SARS-CoV-2, JAMA Network Open, published online 26 February 2021. Access here.
Marks et al, Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study, Lancet Infectious Diseases, published online 2 February 2021. Access here.
Johansson et al, SARS-CoV-2 transmission from people without COVID-19 symptoms, JAMA Network OPEN, published online 7 January 2021. Access here.
Madewell et al, Household transmission of SARS-CoV-2. A systematic review and meta-analysis, JAMA Network OPEN, published online 14 December 2020. Access here.
Clapp et al, Evaluation of cloth masks and modified procedure masks as Personal Protective Equipment for the public during the COVID-19 pandemic, JAMA Internal Medicine, published online 10 December 2020. Access here.
Laws et al, Symptoms and transmission of SARS-CoV-2 among children — Utah and Wisconsin, March–May 2020, Pediatrics, published online 1 December 2020. Access here.
Bulfone et al, Outdoor transmission of SARS-CoV-2 and other respiratory viruses, a systematic review, The Journal of Infectious Diseases, jiaa742, published online 29 November 2020. Access here.
van Dorp et al, No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2, Nature Communications, published online 25 November 2020. Access here.
Sun et al, Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2, Science, published online 24 November 2020. Access here.
Kasper et al, An outbreak of Covid-19 on an aircraft carrier, NEJM, published online 11 November 2020. Access here.
Viner et al, Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults – A Systematic Review and Meta-analysis, JAMA Pediatrics, published online 25 September 2020. Access here.
Macartney et al, Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study, Lancet Child and Adolescent Health, published online 3 August 2020. Access here.
Sekizuka et al, Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak, PNAS, published online 28 July 2020. Access here.
Hao et al, Reconstruction of the full transmission dynamics of COVID-19 in Wuhan, Nature, published online 16 July 2020. Access here.
Chu et al, Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis, Lancet, published online 1 June 2020. Access here.
Jiang et al, Detection of severe acute respiratory syndrome coronavirus 2 RNA on surfaces in quarantine rooms. Emerging Infectious Diseases, published online 18 May 2020. Access here.
Xiao et al, Infectious SARS-CoV-2 in feces of patient with severe COVID-19, Emerging Infectious Diseases, published online 18 May 2020. Access here.
Liu et al, Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathogens, published online 14 May 2020. Access here.
Liu et al, Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals, Nature, published online 27 April 2020. Access here.
Rothe et al, Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany, NEJM, published online 30 Jan 2020. Access here.
Li et al, Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia, NEJM, published online Jan 29 2020. Access here.
Phan et al, Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam, NEJM, published online Jan 28 2020. Access here.
Chan et al, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, published online Jan 24 2020. Access here.

[Back to top]

Disease and other modelling

Golding et al, A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence, eLife, published online 20 January 2023. Access here.
Houdroge et al, Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts, Scientific Reports, published online 25 January 2023. Access here.
Marcato et al, Learnings from the Australian first few X household transmission project for COVID-19, Lancet Regional Health Western Pacific, published online 5 September 2022. Access here.
Steele et al, Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021, JAMA Network Open, published online 6 July 2022. Access here.
Watson et al, Global impact of the first year of COVID-19 vaccination: a mathematical modelling study, Lancet Infectious Diseases, published online 23 June 2022. Access here.
Cabore et al, COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns, Lancet Global Health, published online 1 June 2022. Access here.
Woolf et al, Changes in life expectancy between 2019 and 2020 in the US and 21 peer countries, JAMA Network Open, published online 13 April 2022. Access here.
Zachreson et al, COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2, Science Advances, published online 8 April 2022. Access here.
Marcato et al, The ongoing value of first few X studies for COVID-19 in the Western Pacific Region, Western Pacific Surveillance and Response Journal, published online 24 March 2022. Access here.
Shearer et al, Rapid assessment of the risk of SARS-CoV-2 importation: case study and lessons learned, Epidemics, published online 24 February 2022. Access here.
McVernon et al, Doherty Modelling–Final report to National Cabinet 5th November 2021. Access here.
Reitsma et al, Quantifying and benchmarking disparities in COVID-19 vaccination rates by race and ethnicity, JAMA Network Open, published online 20 October 2021. Access here.
Baker et al, Optimal allocation of PCR tests to minimise disease transmission through contact tracing and quarantine, Epidemics, published online 25 September 2021. Access here.
Dabbah et al, Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study, Scientific Reports, published online 19 August 2021. Access here.
McVernon et al, Doherty Modelling Report for National Cabinet 30 July 2021, published online 3 August 2021. Access here.
Blakely et al, Association of simulated COVID-19 policy responses for social restrictions and lockdowns with health-adjusted life-years and costs in Victoria, Australia, JAMA Health Forum, published online 30 July 2021. Access here.
Pham et al, Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study, Lancet Global Health, published online 12 April 2021. Access here.
Pavelka et al, The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia, Science, published online 23 March 2021. Access here.
Scott et al, Modelling the impact of relaxing COVID‐19 control measures during a period of low viral transmission, MJA, published online 1 February 2021. Access here.
Bubar et al, Model-informed COVID-19 vaccine prioritization strategies by age and serostatus, Science, published online 21 January 2021. Access here.
Lavine et al, Immunological characteristics govern the transition of COVID-19 to endemicity, Science, published online 12 January 2021. Access here.
Brauner et al, Inferring the effectiveness of government interventions against COVID-19, Science, published online 15 December 2020. Access here.
Chang et al, Modelling transmission and control of the COVID-19 pandemic in Australia, Nature Communications, published online 11 November 2020. Access here.
Chang et al, Mobility network models of COVID-19 explain inequities and inform reopening, Nature, published online 10 November 2020. Access here.
Li et al, The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries, Lancet Infectious Diseases, published online 22 October 2020. Access here.
Moss et al, Coronavirus disease model to inform transmission reducing measures and health system preparedness, Australia, Emerging Infectious Diseases, published online 28 September 2020. Access here.
Abeysuriya et al, Estimating risks associated with early reopening in Victoria, Melbourne, Australia, Burnet Institute, 26 September 2020. Access here.
Russell et al, COVID-19 in Victorian Schools, An analysis of child-care and school outbreak data and evidence-based recommendations for opening schools and keeping them open, Melbourne, Australia: Murdoch Children’s Research Institute and the University of Melbourne, 25 September 2020. Access here.
Blakely et al, The probability of the 6-week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS-CoV-2, Medical Journal of Australia, mja20.01292 [Pre-print, 4 September 2020], pre-print 4 September 2020. Access here.
Bilinski et al, Modeling contact tracing strategies for COVID-19 in the context of relaxed physical distancing measures, JAMA Network Open, published online 21 August 2020. Access here.
Price et al, Early analysis of the Australian COVID-19 epidemic, eLife, published online 13 August 2020. Access here.
Kretzschmar et al, Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study, Lancet Public Health, published online 16 July 2020. Access here.
Hogan et al, Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study, Lancet Global Health, published online 13 July 2020. Access here.
Clark et al, Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study, Lancet Global Health, published online 15 June 2020. Access here.
Narayanan, A novel cohort analysis approach to determining the case fatality rate of COVID-19 and other infectious diseases, PLoS ONE, published online 15 June 2020. Access here.
Hsiang et al, The effect of large-scale anti-contagion policies on the COVID-19 pandemic, Nature, published online 8 June 2020. Access here.
Flaxman et al, Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe, Nature, published online 8 June 2020. Access here.
Golding et al, Estimating temporal variation in transmission of COVID-19 and adherence to social distancing measures in Australia, Technical report posted online 15 May 2020. Access here.
Gardiner et al, Royal Flying Doctor Service COVID-19 activity and surge modelling in Australia, Air Medical Journal, published online May 2020. Access here.
Peak et al, Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study, Lancet Infectious Diseases, published online 20 May 2020. Access here.
Price et al, Early analysis of the Australian COVID-19 epidemic [pre-print], medRxiv, posted online 30 April 2020. Access here.
Shearer et al, Assessing the risk of spread of COVID-19 to the Asia Pacific region, medRxiv, posted online 19 April 2020. Access here.
Price et al, Estimating the case detection rate and temporal variation in transmission of COVID-19 in Australia, Technical report posted online 14 April 2020. Access here.
Moss et al, Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness, medRxiv, posted online 11 April 2020. Access here.
Fox et al, Modelling the impact of COVID-19 upon intensive care services in New South Wales, Medical Journal of Australia [preprint version], published online 30 March 2020. Access here.
Verity et al, Estimates of the severity of coronavirus disease 2019: a model-based analysis, Lancet Infectious Diseases, published online 30 March 2020. Access here.
Koo et al, Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study, Lancet Infectious Diseases, published online 23 March 2020. Access here.
Lai et al, Assessing spread risk of Wuhan novel coronavirus within and beyond China, January-April 2020: a travel network-based modelling study, medRxiv, posted online 9 March 2020. Access here.
Wu et al, Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study, Lancet, published online 31 Jan 2020. Access here.
Leung and Wu, Real-time nowcast and forecast on the extent of the Wuhan CoV outbreak, domestic and international spread, Media Conference Jan 27 2020. Download PDF.
Imai et al, Report 3: Transmissibility of 2019-nCoV, published online Jan 25 2020. Download PDF
Chinazzi et al, Preliminary assessment of the international spreading risk associated with the 2019 novel coronavirus (2019-nCoV) outbreak in Wuhan City, Center for Inference & Dynamics of Infectious Diseases, published online Jan 17 2020. Download PDF.
Bogoch et al, Pneumonia of unknown etiology in Wuhan, China: Potential for international spread via commercial air travel, Journal of Travel Medicine, published online Jan 14 2020. Access here.

[Back to top]

Virology, immunity and diagnostics

Link-Gelles et al, Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection — Increasing community access to testing program, United States, September–November 2022, Morbidity and Mortality Weekly Report, 22 November 2022. Access here.
Nielsen et al, Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study, PLOS Medicine, 22 November 2022. Access here.
Maringer et al, Durable spike-specific T-cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination, Science Immunology, published online 1 November 2022. Access here.
Di Chiara et al, Long-term immune response to SARS-CoV-2 infection among children and adults after mild infection, JAMA Network Open, published online 13 July 2022. Access here.
Wang et al, Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, & BA.5, Nature, published online 5 July 2022. Access here.
Fernández-Castañeda et al, Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation, Cell, published online 12 June 2022. Access here.
Grandjean et al, Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction, PLOS ONE, published online 1 June 2022. Access here.
Aggarwal et al, Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia, Nature Microbiology, published online 30 May 2022. Access here.
Muecksch et al, Increased memory B Cell potency and breadth after a SARS-CoV-2 mRNA boost, Nature, published online 21 April 2021. Access here.
Junqueira et al, FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation, Nature, published online 6 April 2022. Access here.
Bar-On et al, Protection by a fourth dose of BNT162b2 against omicron in Israel, NEJM, published online 5 April 2022. Access here.
Killingley et al, Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults, Nature Medicine, published online 31 March 2022. Access here.
Kousathanas et al, Whole genome sequencing reveals host factors underlying critical Covid-19, Nature, published online 7 March 2022. Access here.
Chu et al, Risk of second allergic reaction to SARS-CoV-2 vaccines. A systematic review and meta-analysis, JAMA Internal Medicine, published online 21 February 2022. Access here.
Yin et al, Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody, Science, published online 8 February 2022. Access here.
Bond et al, Utility of SARS-CoV-2 Rapid Antigen Testing for Patient Triage in the Emergency Department: A Clinical Implementation Study in Melbourne, Australia, Lancet, published online 2 February 2022. Access here.
McCallum et al, Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement, Science, published online 25 January 2022. Access here.
Kundu et al, Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts, Nature Communications, published online 10 January 2022. Access here.
Fulford et al, A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2, EBioMedicine, published online 3 December 2021. Access here.
Boyton and Altmann, The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions? Nature Reviews Immunology, published online 19 October 2021. Access here.
Au et al, Diagnostic performances of common nucleic acid tests for SARS-CoV-2 in hospitals and clinics: a systematic review and meta-analysis, Lancet Microbe, published online 12 October 2021. Access here.
Bond et al, Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection, Pathology, volume 53, issue 6, pp773–779, 1 October 2021. Access here.
Townsend et al, The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study, Lancet Microbe, published online 1 October 2021. Access here.
COVID-19 Host Genetics Initiative, Mapping the human genetic architecture of COVID-19, Nature, published online 8 July 2021. Access here.
Tea et al, SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants, PLOS Medicine, published online 6 July 2021. Access here.
Chamings et al, An increased ratio of SARS-CoV-2 positive to negative sense genomic and subgenomic RNAs within routine diagnostic upper respiratory tract swabs may be a marker of virion shedding, medRxiv [Preprint], published online 3 July 2021. Access here.
Cai et al, Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants, Science, published online 24 June 2021. Access here.
Yazaki et al, Difference in SARS-CoV-2 antibody status between patients with cancer and health care workers during the COVID-19 pandemic in Japan, JAMA Oncology, published online 28 May 2021. Access here.
Revollo et al, Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial, Lancet Infectious Diseases, published online 27 May 2021. Access here.
Turner et al SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans, Nature, published online 24 May 2021. Access here.
Nicholson et al, Evaluation of 6 commercial SARS-CoV-2 serology assays detecting different antibodies for clinical testing and serosurveillance, Open Forum Infectious Disease, published online 10 May 2021. Access here.
Nguyen et al, CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naïve precursor frequency and T cell receptor promiscuity, Immunity, published online 15 April 2021. Access here.
Selva et al, Systems serology detects functionally distinct coronavirus antibody features in children and elderly, Nature Communications, published online 1 April 2021. Access here.
Garcia-Beltran et al, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, Cell, published online 12 March 2021. Access here.
Muhi et al, Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study, Lancet Regional Health Western Pacific, published online 2 March 2021. Access here.
Yaren et al, Ultra-rapid detection of SARS-CoV-2 in public workspace environments, PLOS ONE, published online 25 February 2021. Access here.
Zhang et al, Emergence of a novel SARS-CoV-2 variant in Southern California, JAMA, published online 11 February 2021. Access here.
Bonifacius et al, COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses, Immunity, published online 9 February 2021. Access here.
Greaney et al, Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies, Cell Host and Microbe, published online 8 February 2021. Access here.
Butler-Laporte et al, Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2. A systematic review and meta-analysis, JAMA Internal Medicine, published online 15 January 2021. Access here.
Grant et al, Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia, Nature, published online 11 January 2021. Access here.
Dan et al, Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection, Science, 6 January 2021. Access here.
Bailey and Diamond, A Crisp(r) new perspective on SARS-CoV-2 biology, Cell, published online 17 December 2020. Access here.
Garcia-Beltran et al, COVID-19 neutralizing antibodies predict disease severity and survival, Cell, published online 9 December 2020. Access here.
Alexandersen et al, SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication, Nature Communications, published online 27 November 2020. Access here.
Liotti et al, Assessment of SARS-CoV-2 RNA test results among patients who recovered from COVID-19 with prior negative results, JAMA Internal Medicine, published online 12 November 2020. Access here.
Ng et al, Preexisting and de novo humoral immunity to SARS-CoV-2 in humans, Science abe1107, published online 6 Nov 2020. Access here.
Weisberg et al, Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum, Nature Immunology, published online 5 Nov 2020. Access here.
Chen et al, Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production, Cell, published online 3 November 2020. Access here.
Seow et al, Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans, Nature Microbiology, published online 26 October 2020. Access here.
Daniloski et al, Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells, Cell, published online 24 October 2020. Access here.
Zhang at al, Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, Science, published online 23 October 2020. Access here.
Kociolek et al, Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs, Journal of Clinical Microbiology, published online October 22 2020. Access here.
Huang et al, A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity, Nature Communications, published online 17 September 2020. Access here.
Mlcochova et al, Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following eEmergence of D614G spike variant, Cell Reports Medicine, published online 1 September 2020. Access here.
Gudbjartsson et al, Humoral immune response to SARS-CoV-2 in Iceland, NEJM, published online 1 September 2020. Access here.
Seemann et al, Tracking the COVID-19 pandemic in Australia using genomics, Nature Communications, published online 1 September 2020. Access here.
Takahashi et al, Sex differences in immune responses that underlie COVID-19 disease outcomes, Nature, published online 26 August 2020. Access here.
Sekine et al, Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19, Cell, published online 14 August 2020. Access here.
Braun et al, SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19, Nature, published online 19 July 2020. Access here.
Brann et al, Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia, Science Advances, published online 28 July 2020. Access here.
Chandrashekar et al, SARS-CoV-2 infection protects against rechallenge in rhesus macaques, Science, published online 20 May 2020. Access here.
Ni et al, Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals, Immunity, published online 3 May 2020. Access here.
Ziegler et al, [Pre-proof] SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues, Cell, published online 29 April 2020 . Access here.
Rockx et al, Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model, Science, published online 17 April 2020. Access here.
He et al, Temporal dynamics in viral shedding and transmissibility of COVID-19, Nature Medicine, published online 15 April 2020. Access here.
Caly et al, Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia, Medical Journal of Australia, published online 13 April 2020. Access here.
Caly et al, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Research, published online 3 April 2020. Access here.
Walls et al, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, published online 9 March 2020. Access here.
Wu et al, Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China, Cell Host & Microbe, published 7 Feb 2020. Access here.
Corman et al, Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, Eurosurveillance, published online Jan 23 2020. Access here.
Zhou et al, Discovery of a novel coronavirus associated with the recent pneumonia outbreak in 2 humans and its potential bat origin, bioRxiv, posted online Jan 23 2020. Access here.
Killerby et al, Human coronavirus circulation in the United States 2014–2017, Journal of Clinical Virology, 101: 52–56, 2018. Access here.

[Back to top]

Vaccines and treatments

Yamamoto et al, Analysis of previous infection, vaccinations, and anti–SARS-CoV-2 antibody titers and protection against infection with the SARS-CoV-2 Omicron BA.5 variant, JAMA Network Open, published 16 March 2023. Access here.
Tenforde et al, Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults — VISION Network, Nine States, September–November 2022, Morbidity and Mortality Weekly Report, published online 15 December 2022. Access here.
Marra et al, The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions: A systematic literature review and meta-analysis, Antimicrobial Stewardship & Healthcare Epidemiology, published online 6 December 2022. Access here.
Ng et al, Analysis of COVID-19 incidence and severity among adults vaccinated with 2-dose mRNA COVID-19 or inactivated SARS-CoV-2 vaccines with and without boosters in Singapore, JAMA Network Open, published online 26 August 2022. Access here.
Faustman et al, Multiple BCG vaccinations for prevention of COVID-19 and other infectious diseases in Type 1 diabetes, Cell Reports Medicine, published online 15 August 2022. Access here.
Cohen et al, Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel, JAMA Network Open, published online 2 August 2022. Access here.
Pitre et al, Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis, Canadian Medical Association Journal, published online 25 July 2022. Access here.
Tartof et al, Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants, Lancet Respiratory Medicine, published online 6 May 2022. Access here.
Andrews et al, Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant, NEJM, published online 2 March 2022. Access here.
Accorsi et al, Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants, JAMA Network, published online 21 January 2022. Access here.
Rosenberg et al, Covid-19 vaccine effectiveness in New York State, NEJM, 2022; 386:116-127. Access here.
Zeng et al, Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials, Lancet Infectious Diseases, published online 7 December 2021. Access here.
Munro et al, Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial, Lancet, published online 2 December 2021, Access here.
Tartof et al, Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study, Lancet, published online 4 October 2021. Access here.
Antonelli et al, Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study, Lancet Infectious Diseases, published online 1 September 2021. Access here.
An et al, Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2, iScience, published online 26 August 2021. Access here.
Bernal et al, Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant, NEJM, published online 12 August 2021. Access here.
Esteve-Palau et al, Quantification of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with an mRNA vaccine, JAMA Network Open, published online 11 August 2021. Access here.
Bergwerk et al, Covid-19 breakthrough infections in vaccinated health care workers, NEJM, published online 28 July 2021. Access here.
Hull et al, The impact of the COVID‐19 pandemic on routine vaccinations in Victoria, Medical Journal of Australia, published online 19 July 2021. Access here.
Frenck et al, Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents, NEJM, published online 15 July 2021. Access here.
Subbarao, The success of SARS-CoV-2 vaccines and challenges ahead, Cell Host and Microbe, volume 29, issue 7, p1111–1123, July 14, 2021. Access here.
Fareh et al, Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance, Nature Communications, published online 13 July 2021. Access here.
Huynh et al, Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia, Nature, published online 7 July 2021. Access here.
The WHO REACT working group, Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19 – A meta-analysis, JAMA, published online 6 July 2021. Access here.
McArdle et al, Treatment of multisystem inflammatory syndrome in children, NEJM, published online 1 July 2021. Access here.
Thompson et al, Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines, NEJM, published online 20 June 2021. Access here.
Ku et al, Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants, Nature, published online 3 June 2021. Access here.
Massarweh, et al, Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer, JAMA Oncology, published online 28 May 2021. Access here.
[Preprint] Lopez Bernal et al, Effectiveness of COVID-19 vaccines against the B.1.617.2 variant, Knowledge Hub, published online 22 May 2021. Access here.
Collier et al, Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women, JAMA, published online 13 May 2021. Access here.
Haas et al, Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data, Lancet, published online 5 May 2021. Access here.
Hacisuleyman et al, Vaccine breakthrough infections with SARS-CoV-2 variants, NEJM, published online 21 April 2021. Access here.
Chappell et al, Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial, Lancet Infectious Diseases, published online 19 April 2021. Access here.
Greinacher et al, Thrombotic hrombocytopenia after ChAdOx1 nCov-19 vaccination, NEJM, published online 9 April 2021. Access here.
Gray et al, COVID-19 vaccine response in pregnant and lactating women: a cohort study, American Journal of Obstetrics and Gynecology, published online 25 March 2021. Access here.
Madhi et al, Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant, NEJM, published online 16 March 2021. Access here.
López-Medina et al, Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19. A randomized clinical trial, JAMA, published online 4 March 2021. Access here.
Prendecki et al, Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine, Lancet, published online 25 February 2021. Access here.
The RECOVERY Collaborative Group, Dexamethasone in hospitalized patients with Covid-19, NEJM, published online 25 February 2021. Access here.
Janiaud et al, Association of convalescent plasma treatment With clinical outcomes in patients with COVID-19.
A systematic review and meta-analysis, JAMA, published online 26 February 2021. Access here.
REMAP-CAP Investigators, Interleukin-6 receptor antagonists in critically ill patients with Covid-19, NEJM, published online 25 February 2021. Access here.
Dagan et al, BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting, NEJM, published online 24 February 2021. Access here.
Voysey et al, Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials, Lancet, published online 19 February 2021. Access here.
Yang et al, An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study, Scientific Reports, published online 5 February 2021. Access here.
Kemp et al, SARS-CoV-2 evolution during treatment of chronic infection, Nature, published online 5 February 2021. Access here.
Logunov et al, Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia, Lancet, published online 2 February 2021. Access here.
Sadoff et al, Interim results of a Phase 1–2a trial of Ad26.COV2.S Covid-19 vaccine, NEJM, published online 13 January 2021. Access here.
Libster et al, Early high-titer plasma therapy to prevent severe Covid-19 in older adults, NEJM, published online 6 January 2021. Access here.
Baden et al, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, NEJM, published online 30 December 2020. Access here.
Weinreich et al, REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19, NEJM, published online 17 December 2020. Access here.
Kalil et al, Baricitinib plus remdesivir for hospitalized adults with Covid-19, NEJM, published online 11 December 2020. Access here.
Zhang et al, Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial, Lancet Infectious Diseases, published online 17 November 2020. Access here.
Lenze et al, Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19. A Randomized Clinical Trial, JAMA, published online 12 November 2020. Access here.
Monk et al, Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial, Lancet Respiratory Medicine, published online 12 November 2020. Access here.
Beigel et al, Remdesivir for the treatment of Covid-19 — Final Report, NEJM, published online 5 November 2020. Access here.
Barnes et al, SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies, Nature, published online 12 October 2020. Access here.
RECOVERY Collaborative Group, Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet, published online 5 October 2020. Access here.
Abella et al, Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers. A Randomized Clinical Trial, JAMA Internal Medicine, published online 30 September 2020. Access here.
Anderson et al, Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults, NEJM, published online 29 September 2020. Access here.
Lund et al, Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study, PLOS Medicine, published online 8 September 2020. Access here.
Logunov et al, Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia, Lancet, published online 4 September 2020. Access here.
Dinnon III et al, A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures, Nature, published online 27 August 2020. Access here.
Xia et al, Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes interim analysis of 2 randomized clinical trials, JAMA, published online 13 August 2020. Access here.
Greenhalgh et al, Management of post-acute covid-19 in primary care, BMJ, published online 11 August 2020. Access here.
Liu et al, Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike, Nature, published online 22 July. Access here.
Folegatti et al, Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, The Lancet, published online 20 July 2020. Access here.
The RECOVERY Collaborative Group, Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report, NEJM, published online 17 July 2020. Access here.
Jackson et al, An mRNA Vaccine against SARS-CoV-2 — Preliminary Report, NEJM, published online 14 July 2020. Access here.
Zhu et al, Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial, Lancet, published online 22 May 2020. Access here.
Pinto et al, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature, published online 18 May 2020. Access here.
Bojkova et al, Proteomics of SARS-CoV-2-infected host cells reveals therapy targets, Nature, published online 14 May 2020. Access here.
Rosenberg et al, Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State, JAMA, published online 11 May 2020. Access here.
Wang et al, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, pulished online 29 April 2020. Access here.
Duan et al, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, PNAS, published online 6 April 2020. Access here.
Eyal et al, Human challenge studies to accelerate coronavirus vaccine licensure, The Journal of Infectious Diseases, published online 31 March 2020. Access here.

[Back to top]

Preparedness, ethics and other COVID-related research

Basseal et al, Key lessons from the COVID-19 public health response in Australia, Lancet Regional Health Western Pacific, published online 10 October 2022. Access here.
Wyer et al, Exploring healthcare workers’ perspectives of video feedback for training in the use of powered air purifying respirators (PAPR) at the onset of the COVID-19 pandemic, BMC Medical Education, published online 23 September 2022. Access here.
Hor et al, ‘Like building a plane and flying it all in one go’: an interview study of infection prevention and control in Australian general practice during the first 2 years of the SARS-CoV-2 pandemic, BMJ Open, published online 19 September 2022. Access here.
Sachs et al, The Lancet Commission on lessons for the future from the COVID-19 pandemic, Lancet, published online 14 September 2022. Access here.
Hillis et al, Orphanhood and caregiver loss among children based on new global excess COVID-19 death estimates, JAMA Pediatrics, published online 6 September 2022. Access here.
Tan et al, A call for citizen science in pandemic preparedness and response: beyond data collection, BMJ Global Health, published June 2022. Access here.
Williams Veazey et al, Paradoxes of pandemic infection control: Proximity, pace and care within and beyond SARS-CoV-2, SSM – Qualitative Research in Health, published online 7 June 2022. Access here.
Ayton et al, Experiences of personal protective equipment by Australian healthcare workers during the COVID-19 pandemic, 2020: A cross-sectional study, PLOS ONE, published online 7 June 2022. Access here.
Seale et al, The role of community leaders and other information intermediaries during the COVID-19 pandemic: insights from the multicultural sector in Australia, Humanities and Social Sciences Communications, published online 17 May 2022. Access here.
Haire et al, Experiences of risk in Australian hotel quarantine: a qualitative study, BMC Public Health, published online 12 May 2022. Access here.
Quigley et al, Estimated mask use and temporal relationship to COVID-19 epidemiology of Black Lives Matter protests in 12 cities, Journal of Racial and Ethnic Health Disparities, published 11 May 2022. Access here.
Butterworth et al, Effect of lockdown on mental health in Australia: evidence from a natural experiment analysing a longitudinal probability sample survey, Lancet Public Health, published online 21 April 2022. Access here.
Aknin et al, Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countries, Lancet Public Health, published online 21 April 2022. Access here.
Lewis et al, Transmission of SARS-CoV-2 in standardised First Few X cases and household transmission investigations: a systematic review and meta-analysis, MedRxiv, published online 15 April 2022. Access here.
Gilbert and Kerridge, What is needed to sustain improvements in hospital practices post-COVID-19? A qualitative study of interprofessional dissonance in hospital infection prevention and control, BMC Health Services Research, published online 14 April 2022. Access here.
Vogt et al, Contact tracing indicators for COVID-19: Rapid scoping review and conceptual framework, PLOS ONE, published online 28 February 2022. Access here.
McDermid et al, How have governments supported citizens stranded abroad due to COVID-19 travel restrictions? A comparative analysis of the financial and health support in eleven countries, BMC Infectious Diseases, published online 20 February 2022. Access here.
Spilg et al, The new frontline: exploring the links between moral distress, moral resilience and mental health in healthcare workers during the COVID-19 pandemic, BMC Psychiatry, published online 6 January 2022. Access here.
Shet et al, Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories, Lancet Global Health, published online 21 December 2021. Access here.
Broom et al, Experiences of the SARS-CoV-2 pandemic amongst Australian Healthcare workers: From stressors to protective factors, Journal of Hospital Infection, published online 10 December 2021. Access here.
Broom et al, “One minute it’s an airborne virus, then it’s a droplet virus, and then it’s like nobody really knows…”: Experiences of pandemic PPE amongst Australian healthcare workers, Infection, Disease and Health, published online 23 November 2021. Access here.
Williams Veazey et al, Entanglements of affect, space, and evidence in pandemic healthcare: An analysis of Australian healthcare workers’ experiences of COVID-19, Health & Place, volume 72, November 2021, 102693. Access here.
Bastani et al, Efficient and targeted COVID-19 border testing via reinforcement learning, Nature, published online 22 September 2021. Access here.
Leask et al, Policy considerations for mandatory COVID-19 vaccination from the Collaboration on Social Science in Immunisation, Medical Journal of Australia, published online 12 September 2021. Access here.
Hillis et al, Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study, Lancet, published online 20 July 2020. Access here.
Solís Arce et al, COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries, Nature Medicine, published online 16 July 2021. Access here.
Geerts et al, Guidance for Health Care Leaders During the Recovery Stage of the COVID-19 Pandemic. A Consensus Statement, JAMA Network Open, published online 8 July 2021. Access here.
Leask et al, Communicating with patients and the public about COVID‐19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation, Medical Journal of Australia, published online 5 July 2021. Access here.
Bhattacharjee et al, Experimental Evidence for the Optimal Design of a High-Performing Cloth Mask, ACS Biomaterials Science & Engineering, published online 21 May 2021. Access here.
Wymant et al, The epidemiological impact of the NHS COVID-19 App, Nature, published online 12 May 2021. Access here.
Pickles et al, COVID-19 misinformation trends in Australia: Prospective longitudinal national survey, Journal of Medical Internet Research, 2021;23(1):e23805. Access here.
Smith and Massey, Value of consultation in establishing a public health research network: lessons from APPRISE, Public Health Research and Practice, published online 9 February 2021. Access here.
Seligman et al, Social determinants of mortality from COVID-19: A simulation study using NHANES, PLOS Medicine, published online 11 January 2021. Access here.
Williams et al, How should we conduct pandemic vaccination?, Vaccine, published online 8 January 2021. Access here.
Fielding et al, Constructing an ethical framework for priority allocation of pandemic vaccines, Vaccine, published online 3 January 2021. Access here.
Degeling et al, Priority allocation of pandemic influenza vaccines in Australia – Recommendations of 3 community juries, Vaccine, Published online 13 December 2020. Access here.
Degeling et al, Changes in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment, BMJ Open, published online 18 November 2020. Access here.
Lazarus et al, COVID-SCORE: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10), PLoS ONE, published online 6 October 2020. Access here.
Sutton et al, COVID-19: Retransmission of official communications in an emerging pandemic, PLOS ONE, published online 16 September 2020. Access here.
Emanuel et al, An ethical framework for global vaccine allocation, Science, published online 11 September 2020. Access here.
Dawson et al, An ethics framework for making resource allocation decisions within clinical care: Responding to COVID-19, Journal of Bioethical Inquiry, published online 25 August 2020. Access here.
Dawson. Building an ethics framework for COVID-19 resource allocation: The How and the Why, Journal of Bioethical Inquiry, published online 25 August 2020. Access here.
Vaughn et al, Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: A multi-hospital cohort study, Clinical Infectious Diseases, published online 21 August 2020. Access here.
McGrail et al, Enacting national social distancing policies corresponds with dramatic reduction in COVID19 infection rates, PLOS ONE, published online 30 July 2020. Access here.
Peltier et al, Addressing decontaminated respirators: some methods appear to damage mask integrity and protective function, Infection Control & Hospital Epidemiology, published online 16 July 2020. Access here.
Research Data Alliance COVID-19 Working Group, RDA COVID-19 recommendations and guidelines for data sharing, Research Data Alliance, published online 30 June 2020. Access here.
Tangcharoensathien et al, Framework for managing the COVID-19 infodemic: Methods and results of an online, crowdsourced WHO technical consultation, Journal of Medical Internet Research, published online 26 June 2020. Access here.
Block et al, Social network-based distancing strategies to flatten the COVID-19 curve in a post-lockdown world, Nature Human Behaviour, published online 4 June 2020. Access here.
Dawson et al, Key ethical concepts and their application to COVID-19 research, Public Health Ethics, published online 15 May 2020. Access here. DOI link – not yet active
Black et al, Living with COVID-19: Planning policy for the next stage, published online 7 May 2020. Access here.
Bartozsco et al, Medical masks vs N95 respirators for preventing COVID‐19 in health care workers a systematic review and meta‐analysis of randomized trials, Influenza and Other Respiratory Viruses, published online 4 April 2020. Access here.
Dawson et al, An ethics framework for making resource allocation decisions within clinical care: Responding to COVID-19, Version 1 published online 2 April 2020. Access here.
Brett-Major et al, Advanced preparation makes research in emergencies and isolation care possible: The case of coronavirus disease, The American Society of Tropical Medicine and Hygiene, published online 30 March 2020. Access here.
Shearer et al, Infectious disease pandemic planning and response: Incorporating decision analysis, PLoS Medicine, published online 9 January 2020. Access here.

[Back to top]

Publisher platforms with free papers relevant to the outbreak

[Back to top]

Network links

Global links

World Health Organization
GloPID-R – the international network of research funding organizations
ISARIC – International Severe Acute Respiratory and Emerging Infection Consortium
US CDC Centers for Disease Control and Prevention
REACTing – a network of French research institutions working on emerging infectious diseases
ANRS | Maladies infectieuses émergentes – French Agency for Research on AIDS and Viral Hepatitis and emerging infectious diseases
GISAID Initiative – Global Initiative on Sharing All Influenza Data, for BetaCoV sequences
http://virological.org/ – A discussion forum for analysis and interpretation of virus molecular evolution and epidemiology – includes information about COVID-19
https://nextstrain.org/ – an open-source project to harness the scientific and public health potential of pathogen genome data – includes information about COVID-19
International Society for Infectious Diseases – COVID-19 page
Global Health Network – Pop-up space for COVID-19

Australian Health links